About the report:
This report titled 'Japanese Competence Centers in Bioinformatics and Computational Biology: A primer for European SMEs' provides an overview of the Japanese competence centers in bioinformatics and computational biology. It begins by summarising the main aspects, regulations and current trends of technology in Japan. It then argues that Japan currently has a strong stake in the life sciences industry which has entered an era of “big data”, particularly in several prominent subsectors such as genome sequencing, quantitative and systems biology, personalized medicine and drug design. This report also identifies the major players in the bioinformatics sector from the point of view of EU SMEs and clusters interested in this growing market.
About the expert:
Professor Rolf Schmid is a consultant with over 40 years’ experience in biotechnology-related R&D and business. Click here to access his profile.
Which opportunities does the Biopharmaceutical market in Japan offer to EU companies?Among Biotechnology, the field of biopharmaceuticals is a core sector in terms of market size and growth potential
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.